Intelligence Β· Patent portfolio
S.L Patents
Full USPTO pharma patent portfolio for S.L β grant dates, expiration, and drug cross-links.
- Patents
- 179
- Expiring β€24m
- 16
Quick answer
S.L has 179 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 16 expire within 24 months β use filters for patent-cliff planning.
-
US 7241799
Cannabimimetic indole derivatives
granted -
US 7186115
Advanced thermoplastics for orthodontics
granted -
US 7183313
Keto cannabinoids with therapeutic indications
granted -
US 7179462
Ξ± (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
granted -
US 7173027
Receptor selective cannabimimetic aminoalkylindoles
granted -
US 7135324
Viral recombinases, related articles, and methods of use thereof
granted -
US 7132109
Using heat shock proteins to increase immune response
granted -
US 7118752
Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I
granted -
US 7118873
Polynucleotides encoding cellular transporters and methods of use thereof
granted -
US 7087723
Albumin-free factor VIII formulations
granted -
US 7057076
Bicyclic and tricyclic cannabinoids
granted -
US 6995187
Peripheral cannabinoid receptor (CB2) selective ligands
expired -
US 6995299
Propagation of human hepatocytes in non-human animals
expired -
US 6984389
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
expired -
US 6962904
Elastin peptide analogs and uses thereof
expired -
US 6900236
Cannabimimetic indole derivatives
expired -
US 6809075
Elastin peptide analogs and uses of same incombination with skin enhancing agents
expired -
US 6794362
Asparagine containing elastin peptide analogs
expired -
US 6777389
Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
expired -
US 6749847
Hybrid cytokine of IL-7 and &bgr;-chain of hepatocyte growth factor
expired -
US 6716607
Chicken interferon gene and novel recombinant DNA
expired -
US 6713772
Free-form fabrication using multi-photon excitation
expired -
US 6692910
Inhibition of a target messenger RNA with a modified U1 small nuclear RNA
expired -
US 6610302
Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I
expired -
US 6586573
Albumin-free Factor VIII formulations
expired -
US 6579900
Anandamide amidase inhibitors as analgesic agents
expired -
US 6525242
Propagation of human hepatocytes in non-human mammals
expired -
US 6506731
Elastin peptide analogs and methods of using same
expired -
US 6451316
Methods for generating antigen-reactive T cells in vitro
expired -
US 6391909
Anandamide inhibitors as analgesic agents
expired -
US 6316153
Free-form fabricaton using multi-photon excitation
expired -
US 6299873
Method for improvement of radiation therapy of malignant tumors
expired -
US 6046009
Diagnosis and treatment of glaucoma
expired -
US 6030954
Targeted delivery of poly- or oligonucleotides to cells
expired -
US 6020465
Recombinant avian type i interferon
expired
Frequently asked questions
How many patents does S.L have?
179 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do S.L patents expire?
16 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory